- Home
- MBI vs ALDX Comparison
MBI vs ALDX Comparison
Compare MBI & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBI
- ALDX
- Stock Information
- Founded
- MBI 1973
- ALDX 2004
- Country
- MBI United States
- ALDX United States
- Employees
- MBI N/A
- ALDX N/A
- Industry
- MBI Property-Casualty Insurers
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- MBI Finance
- ALDX Health Care
- Exchange
- MBI Nasdaq
- ALDX Nasdaq
- Market Cap
- MBI 311.3M
- ALDX 304.9M
- IPO Year
- MBI 1987
- ALDX 2014
- Fundamental
- Price
- MBI $5.41
- ALDX $6.91
- Analyst Decision
- MBI Buy
- ALDX Strong Buy
- Analyst Count
- MBI 2
- ALDX 2
- Target Price
- MBI $6.75
- ALDX $10.00
- AVG Volume (30 Days)
- MBI 440.9K
- ALDX 607.7K
- Earning Date
- MBI 05-08-2025
- ALDX 05-01-2025
- Dividend Yield
- MBI N/A
- ALDX N/A
- EPS Growth
- MBI N/A
- ALDX N/A
- EPS
- MBI N/A
- ALDX N/A
- Revenue
- MBI $27,000,000.00
- ALDX N/A
- Revenue This Year
- MBI N/A
- ALDX N/A
- Revenue Next Year
- MBI N/A
- ALDX N/A
- P/E Ratio
- MBI N/A
- ALDX N/A
- Revenue Growth
- MBI 285.71
- ALDX N/A
- 52 Week Low
- MBI $3.22
- ALDX $2.71
- 52 Week High
- MBI $7.46
- ALDX $7.20
- Technical
- Relative Strength Index (RSI)
- MBI 37.63
- ALDX 61.80
- Support Level
- MBI $4.93
- ALDX $6.79
- Resistance Level
- MBI $5.67
- ALDX $7.20
- Average True Range (ATR)
- MBI 0.42
- ALDX 0.56
- MACD
- MBI -0.11
- ALDX 0.03
- Stochastic Oscillator
- MBI 20.08
- ALDX 88.02
About MBI MBIA Inc.
MBIA Inc provides financial guaranty insurance for municipal bonds and asset-backed securities in the United States and internationally. It offers an unconditional guarantee to repay the principal and interest on these securities if the issuer defaults. MBIA insures bonds sold in the primary and secondary markets, as well as those held in unit investment trusts and by mutual funds. It operates in three segments: the United States public finance insurance, corporate, and international & structured finance insurance. U.S. public finance insurance portfolio is managed through National Public Finance Guarantee Corporation. International & structured finance insurance business is managed through MBIA Insurance Corporation and its subsidiary.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.